Article Details
Retrieved on: 2021-05-14 10:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
In a Phase II trial, a cannabidiol (CBD) sublingual tablet reduced pain scores in patients with diabetic peripheral neuropathy by approximately 50 ...
Article found on: www.europeanpharmaceuticalreview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here